Dr Reddy’s lab Share Price fall by 2.91% as the Sector saw poor Q2 Performance

On October 28th Dr Reddy’s laboratories stock price declined around 2.91%.

After the whole pharma sector reported a major decline from the year to year basis in the September quarter.

The company had a profit of more than Rs.1000 crores and it straight away declined to Rs.762 crores but it increased Rs.32 crore sequentially.

There was also an increase in quarter to quarter with a total of 2 per cent.

Disadvantages of having loss or decreasing the share prices are:

Declining in net profit and declining in quarterly net profit with falling profit margin.

The company has reported a decline in quarterly net profit with a falling profit margin (YoY).

In these difficult times there is always sometimes a profit and sometimes loss but at the end everything will fall in line slowly and gradually.

Check all Recent News Updates Here